VUKASINOVIC, ALEKSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 120
EU - Europa 68
AS - Asia 55
SA - Sud America 12
AF - Africa 2
Totale 257
Nazione #
US - Stati Uniti d'America 120
SG - Singapore 35
IT - Italia 29
IE - Irlanda 20
BR - Brasile 12
CN - Cina 9
BE - Belgio 5
KR - Corea 4
RU - Federazione Russa 4
SE - Svezia 3
HK - Hong Kong 2
LB - Libano 2
PK - Pakistan 2
AT - Austria 1
CH - Svizzera 1
FR - Francia 1
GB - Regno Unito 1
GR - Grecia 1
IL - Israele 1
MA - Marocco 1
NO - Norvegia 1
PL - Polonia 1
TN - Tunisia 1
Totale 257
Città #
Chandler 20
Dublin 20
Singapore 20
San Mateo 12
Ann Arbor 11
Altamura 7
Perugia 7
Falls Church 6
Medford 6
Santa Clara 6
Andover 5
Boardman 5
Brussels 5
Princeton 5
Lawrence 4
Des Moines 3
Los Angeles 3
Redmond 3
Wilmington 3
Beijing 2
Guangzhou 2
Hong Kong 2
Norwalk 2
Redwood City 2
Saint Petersburg 2
Seoul 2
Ashburn 1
Baoding 1
Bergen 1
Capão da Canoa 1
Caratinga 1
Centro 1
Espinosa 1
Extrema 1
Guiyang 1
Gwanak-gu 1
Harbin 1
Itororó 1
Jarocin 1
London 1
Luoyang 1
Monte Alto 1
Nabeul 1
Pato Branco 1
Porto Alegre 1
Rabat 1
Rehovot 1
Salvador 1
San Paolo di Civitate 1
Santarcangelo di Romagna 1
Santo Ângelo 1
Seongbuk-gu 1
São José 1
Villeurbanne 1
Totale 193
Nome #
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 77
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 74
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 45
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 43
Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives 33
Totale 272
Categoria #
all - tutte 1.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 0 0 0 10 3 0 0
2020/202136 0 3 5 2 21 1 0 1 2 1 0 0
2021/202247 1 11 0 4 2 3 2 10 2 2 4 6
2022/202380 5 19 1 4 6 10 0 2 26 1 5 1
2023/202425 3 3 1 1 0 0 4 0 2 5 2 4
2024/202571 3 6 9 14 31 8 0 0 0 0 0 0
Totale 272